Clifton L. Dalgard is a notable inventor based in Chevy Chase, MD (US). He has made significant contributions to the field of medical research, particularly in the development of innovative solutions for complex health issues. With a total of 4 patents to his name, Dalgard's work has the potential to impact many lives.

Latest Patents

Dalgard's latest patents include groundbreaking inventions such as "Azophenols as ERG oncogene inhibitors." This patent describes selective azophenol inhibitors that target either wild type or altered ERG protein expression, represented by specific compound formulas. Another significant patent is focused on "Biomarkers for diagnosing post-traumatic stress disorder." This invention outlines methods for determining if a subject is at risk of developing PTSD, showcasing Dalgard's commitment to addressing mental health challenges.

Career Highlights

Throughout his career, Clifton L. Dalgard has been associated with the Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. His work at this esteemed organization highlights his dedication to advancing medical research and improving healthcare outcomes for military personnel and civilians alike.

Collaborations

Dalgard has collaborated with esteemed colleagues such as Shiv Srivastava and Albert Dobi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of medical research.

Conclusion

Clifton L. Dalgard's contributions to medical research through his patents and collaborations demonstrate his commitment to innovation and improving health outcomes. His work continues to inspire future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.